February 13, 2017
New York, NY
February 15, 2017
New York, NY
February 23, 2017
New York, NY
May 12, 2017
12:00 PM EsT
Inovio Plymouth Meeting Office
August 08, 2017
04:30 PM ET
September 06, 2017
Boston, MA
September 10, 2017
New York, NY
September 25, 2017
New York, NY
November 08, 2017
04:30 PM EST
November 15, 2017
11:45 AM EST
November 29, 2017
09:00 AM EST
December 06, 2017
09:00 AM EST
January 08, 2018
09:00 AM PST
Hilton Union Square
February 13, 2018
02:15 PM EST
New York, NY
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
February 22, 2018
10:30 AM EST
New York, NY
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
March 14, 2018
04:30 PM EST
April 09, 2018
11:55 AM CET
Monte Carlo, Monaco
May 09, 2018
04:30 PM EST
May 11, 2018
09:00 AM EST
Inovio Plymouth Meeting Office
August 07, 2018
04:30 PM EST
September 05, 2018
10:25 AM
New York, NY
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
September 06, 2018
09:00 AM EST
Boston, MA
October 02, 2018
10:20 AM EST
New York, NY
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
November 08, 2018
04:30 PM EST
November 14, 2018
11:45 AM EST
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
November 27, 2018
01:30 PM EST
New York, NY
December 05, 2018
08:00 AM EST
New York, NY
March 12, 2019
04:30 PM EST
Speaker(s):
-
J. Joseph Kim, President & CEO
April 08, 2019
04:00 PM GMT
London, UK
Speaker(s):
-
J. Joseph Kim, Ph.D., President & CEO
May 08, 2019
09:00 AM EST
660 W. Germantown Pike, Plymouth Meeting, PA 19462
May 09, 2019
04:30 PM EST
Speaker(s):
-
Dr. J. Joseph Kim, President and CEO
July 17, 2019
08:00 AM EST
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
August 08, 2019
04:30 PM EST
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
September 09, 2019
10:50 AM EST
New York, NY
Speaker(s):
-
J. Joseph Kim, PhD, President & CEO
October 02, 2019
01:15 PM EST
New York, NY
Speaker(s):
-
J. Joseph Kim, Ph.D., President & CEO
November 12, 2019
04:30 PM EST
November 19, 2019
10:20 AM EST
New York, NY
Speaker(s):
-
J. Joseph Kim, Ph.D., President & CEO
December 04, 2019
12:30 PM EST
New York, NY
Speaker(s):
-
J. Joseph Kim, Ph.D., President & CEO
January 14, 2020
10:30 AM PST
San Francisco, CA
Speaker(s):
-
J. Joseph Kim, Ph.D., President & CEO
March 12, 2020
04:30 PM EST
May 05, 2020
02:15 PM ET
Speaker(s):
-
J. Joseph Kim, Ph.D., President & CEO
May 14, 2020
02:00 PM EST
May 19, 2020
02:30 PM ET
Speaker(s):
-
J. Joseph Kim, Ph.D., President & CEO
June 01, 2020
10:00 AM ET
August 10, 2020
04:30 PM ET
September 14, 2020
09:30 AM ET
Virtual
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
September 17, 2020
10:40 AM ET
Virtual
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
September 23, 2020
10:50 AM ET
Virtual
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
November 09, 2020
04:30 PM ET
November 17, 2020
08:00 AM ET
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
January 11, 2021
06:00 AM ET
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
March 01, 2021
04:30 PM ET
March 18, 2021
10:40 AM ET
Virtual
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
May 12, 2021
09:30 AM ET
Virtual
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
May 18, 2021
09:45 AM ET
Virtual
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
June 01, 2021
02:00 PM ET
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
August 09, 2021
04:30 PM ET
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
September 13, 2021
07:00 AM ET
Virtual
Speaker(s):
-
J. Joseph Kim, Ph.D., President & CEO
September 21, 2021
09:55 AM ET
Virtual
Speaker(s):
-
J. Joseph Kim, Ph.D., President & CEO
September 30, 2021
12:40 PM ET
Virtual
Speaker(s):
-
J. Joseph Kim, Ph.D., President & CEO
November 09, 2021
04:30 PM ET
Speaker(s):
-
Dr. J. Joseph Kim, President & CEO
November 15, 2021
10:40 AM ET
Virtual
November 18, 2021
03:00 AM ET
Virtual
Speaker(s):
-
J. Joseph Kim, Ph.D., President & CEO
November 30, 2021
08:00 AM ET
Virtual
Speaker(s):
-
J. Joseph Kim, PhD, President & CEO
March 01, 2022
04:30 PM ET
March 15, 2022
08:00 AM ET
Speaker(s):
-
J. Joseph Kim, PhD, President & CEO
May 16, 2022
09:00 AM ET
Virtual
June 08, 2022
01:00 PM ET
New York, NY
August 09, 2022
04:30 PM ET
September 12, 2022
07:00 AM ET
Virtual
Speaker(s):
-
Jacqueline Shea, Ph.D., President & CEO
November 08, 2022
04:30 PM ET
March 01, 2023
04:30 PM ET
March 13, 2023
10:40 AM ET
Virtual
Speaker(s):
-
Jacqueline Shea, Ph.D., President & CEO
May 16, 2023
09:00 AM ET
Virtual
May 17, 2023
04:05 PM ET
New York, NY
Speaker(s):
-
Jacqueline Shea, PhD, President & CEO
June 09, 2023
08:00 AM ET
New York, NY
August 09, 2023
04:30 PM ET
September 12, 2023
04:30 PM ET
New York, NY
Speaker(s):
-
Jacqueline Shea, Ph.D., President & CEO
November 09, 2023
04:30 PM ET
January 24, 2024
12:00 PM ET
Virtual
February 14, 2024
12:40 PM ET
Virtual
Speaker(s):
-
Dr. Jacqueline Shea, President & CEO
March 06, 2024
04:30 PM ET
April 02, 2024
10:00 AM ET
Jordan Medical Education Center at the Perelman Center for Advanced Medicine
Speaker(s):
-
Dr. Jacqueline Shea, President & CEO
May 14, 2024
11:30 AM ET
New York, NY
Speaker(s):
-
Dr. Jacqueline Shea, President & CEO
May 15, 2024
10:00 AM ET
New York, NY
Speaker(s):
-
Dr. Jacqueline Shea, President & CEO
May 20, 2024
12:30 PM ET
New York, NY
Speaker(s):
-
Dr. Jacqueline Shea, President & CEO
May 21, 2024
09:00 AM ET
Virtual
June 11, 2024
11:00 AM ET
Open to institutional clients only.
August 08, 2024
04:30 PM ET
Virtual
September 18, 2024
09:20 AM ET
Rome, Italy
October 19, 2024
06:00 PM ET
October 22, 2024
12:00 PM KST
November 14, 2024
04:30 PM ET
February 12, 2025
03:20 PM ET
Virtual
Dr. Jacqueline Shea, President and CEO, and Dr. Michael Sumner, Chief Medical Officer, will be presenting.
February 23, 2025
12:00 PM PT
Los Angeles, California
Abstract describing the immunological activity of INO-3107 will be presented as a poster titled: “Loss of Detectable HPV-6 Following Induction of Emergent T cells in Patients with Durable Complete Clinical Response to Treatment for Recurrent Respiratory Papillomatosis using INO-3107"
March 18, 2025
04:30 PM ET
April 15, 2025
01:30 PM ET
- Oral presentation: DNA Immunotherapy (INO-3107) Results in a 72% Overall Response Rate in Year 1 for Treatment of Recurrent Respiratory Papillomatosis Caused by HPV-6 & 11
- Panel: Recurrent Respiratory Papillomatosis: Lessons Learned, Clinical Advances and Patient Experiences – Moderated by Kim McClellan, RRP Foundation President
April 21, 2025
11:50 AM ET
Washington, DC
- Oral presentation: A New Frontier in mAb Therapeutics: DNA-Encoded Monoclonal Antibodies (DMAb™) as Next Gen DNA Medicine
April 23:
- Oral presentation: DNA Immunotherapeutics in the Treatment of Cancers and Virally-Mediated Diseases
April 23, 2025
03:40 PM PT
San Diego
- Oral presentation: Advancing DNA Medicine: INO-3107 for Recurrent Respiratory Papillomatosis
May 08, 2025
11:30 AM ET
New York
Fireside Chat (webcast is audio only)
May 09, 2025
03:40 PM GMT
May 20, 2025
09:00 AM ET
Virtual
July 16, 2025
04:30 PM ET
DMAb Technology: The Transformational Potential of Next Gen DNA Medicine in Rare Disease
August 12, 2025
04:30 PM ET
September 05, 2025
07:00 AM ET
October 07, 2025
08:00 AM ET
Poster Title: Employment of the CELLECTRA® in vivo gene delivery platform in a first in human (FIH) DNA encoded monoclonal antibody (DMAb) clinical trial
Poster Title: In vitro-based nonclinical development pathway for a DNA-encoded bispecific T cell activator (DBTA) targeting HER2
October 11, 2025
08:00 AM ET
Poster Title: DNA Immunotherapy (INO-3107) Demonstrates a Durable Response for Treatment of HPV-6/11 Recurrent Respiratory Papillomatosis
October 13, 2025
09:45 AM ET
Presentation Title: Leveraging the Potential of DNA Immunotherapy: Long-Term Efficacy in HPV-6 & 11 Recurrent Respiratory Papillomatosis
October 16, 2025
05:10 AM ET
Presentation Title: DMAb Technology: The Transformational Potential of Next Gen DNA Medicine in Rare Disease
October 19, 2025
08:00 AM ET
Poster Title: DNA Immunotherapy (INO-3107) in HPV-6 & 11 Recurrent Respiratory Papillomatosis – Long-Term Efficacy
October 24, 2025
08:00 AM ET
Presentation Title: Clinical Response to INO-3107 in RRP is Irrespective of Papilloma Microenvironment and Molecular Subtype
E-Poster Title: DNA Immunotherapy (INO-3107) Induces Persistent Immune Responses Resulting in Long-term Efficacy Through Post-Treatment Year 2 for HPV 6&11 RRP
October 29, 2025
05:10 AM ET
Presentation Title: DMAb Technology: The Transformational Potential of Next Gen DNA Medicine in Rare Disease
October 30, 2025
04:20 AM ET
Presentation Title: Immunotherapy, INO-3107, is Well-Tolerated, Effective, and Elicits an Antigen-Specific T-cell Response in Adults with HPV-6 & 11 Recurrent Respiratory Papillomatosis
November 10, 2025
04:30 PM ET
November 14, 2025
01:45 PM ET
Presentation Title: Novel FVIII Secretion Via Non-Viral Vector DNA Medicine Platform